Chengyi Tu

849 total citations
23 papers, 484 citations indexed

About

Chengyi Tu is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Chengyi Tu has authored 23 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Biomedical Engineering. Recurrent topics in Chengyi Tu's work include Pluripotent Stem Cells Research (10 papers), Tissue Engineering and Regenerative Medicine (7 papers) and 3D Printing in Biomedical Research (5 papers). Chengyi Tu is often cited by papers focused on Pluripotent Stem Cells Research (10 papers), Tissue Engineering and Regenerative Medicine (7 papers) and 3D Printing in Biomedical Research (5 papers). Chengyi Tu collaborates with scholars based in United States, India and South Africa. Chengyi Tu's co-authors include Joseph C. Wu, Haodi Wu, Laura J. Suggs, Janet Zoldan, Hao Zhang, D.-S. Lee, Cheng‐Shang Chang, David T. Paik, Mengcheng Shen and Mingxia Gu and has published in prestigious journals such as Cell, ACS Nano and Circulation Research.

In The Last Decade

Chengyi Tu

23 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyi Tu United States 13 209 144 122 77 75 23 484
Liudi Wang China 14 127 0.6× 182 1.3× 147 1.2× 143 1.9× 29 0.4× 36 592
Fabio Bernini Italy 10 327 1.6× 194 1.3× 117 1.0× 47 0.6× 40 0.5× 26 651
Jianfeng Hou China 12 94 0.4× 116 0.8× 75 0.6× 29 0.4× 23 0.3× 50 522
Wenshuai Deng China 12 51 0.2× 62 0.4× 75 0.6× 62 0.8× 10 0.1× 29 358
Jiawei Liao China 17 308 1.5× 81 0.6× 119 1.0× 10 0.1× 53 0.7× 52 749
Jialin Chen China 10 127 0.6× 40 0.3× 22 0.2× 23 0.3× 27 0.4× 33 402
Allison Post United States 9 42 0.2× 95 0.7× 100 0.8× 98 1.3× 30 0.4× 31 324
Barbara J. Muller-Borer United States 14 253 1.2× 113 0.8× 87 0.7× 74 1.0× 14 0.2× 22 508
Andrew E. Pollard United States 15 503 2.4× 257 1.8× 145 1.2× 151 2.0× 33 0.4× 35 992
Pingchuan Zhang China 11 157 0.8× 151 1.0× 71 0.6× 167 2.2× 29 0.4× 44 506

Countries citing papers authored by Chengyi Tu

Since Specialization
Citations

This map shows the geographic impact of Chengyi Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyi Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyi Tu more than expected).

Fields of papers citing papers by Chengyi Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyi Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyi Tu. The network helps show where Chengyi Tu may publish in the future.

Co-authorship network of co-authors of Chengyi Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyi Tu. A scholar is included among the top collaborators of Chengyi Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyi Tu. Chengyi Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tu, Chengyi, Arianne Caudal, Yu Liu, Sanjiv M. Narayan, & Joseph C. Wu. (2025). Modeling heart rhythm using human engineered heart tissues. Nature Protocols. 21(2). 827–850. 1 indexed citations
2.
Zhang, Hao, Phung N. Thai, Rabindra V. Shivnaraine, et al.. (2024). Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. Cell. 187(25). 7143–7163.e22. 25 indexed citations
3.
Tu, Chengyi, Arianne Caudal, Yu Liu, et al.. (2023). Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction. Nature Biomedical Engineering. 8(4). 479–494. 18 indexed citations
4.
Caudal, Arianne, Lu Ren, Chengyi Tu, & Joseph C. Wu. (2022). Human induced pluripotent stem cells for studying mitochondrial diseases in the heart. FEBS Letters. 596(14). 1735–1745. 5 indexed citations
5.
Zhang, Joe Z., Rui Zhao, Chengyi Tu, et al.. (2021). Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes. STAR Protocols. 2(4). 100859–100859. 15 indexed citations
6.
Tu, Chengyi, et al.. (2021). Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity. Frontiers in Pharmacology. 12. 613837–613837. 10 indexed citations
7.
Yang, Huaxiao, Ning‐Yi Shao, Alexandra Holmström, et al.. (2020). Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissue. Cardiovascular Research. 117(9). 2125–2136. 23 indexed citations
8.
Allen, Alicia C. B., et al.. (2019). Temporal Impact of Substrate Anisotropy on Differentiating Cardiomyocyte Alignment and Functionality. Tissue Engineering Part A. 25(19-20). 1426–1437. 17 indexed citations
9.
Crosby, Cody O., Sachin Kumar, Chengyi Tu, et al.. (2019). Quantifying the Vasculogenic Potential of Induced Pluripotent Stem Cell-Derived Endothelial Progenitors in Collagen Hydrogels. Tissue Engineering Part A. 25(9-10). 746–758. 21 indexed citations
10.
Zhang, Hao, Lei Tian, Mengcheng Shen, et al.. (2019). Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis. Circulation Research. 125(5). 552–566. 110 indexed citations
11.
Tu, Chengyi, et al.. (2018). Commonly used thiol-containing antioxidants reduce cardiac differentiation and alter gene expression ratios of sarcomeric isoforms. Experimental Cell Research. 370(1). 150–159. 5 indexed citations
13.
Sangani, L. D. Varma, M. Ghanashyam Krishna, Jiten Das, et al.. (2018). Resistive Switching Behaviour in PMMA/Al:ZnO Composite Films. Acta Physica Polonica A. 134(1). 68–70. 8 indexed citations
14.
15.
Tu, Chengyi, et al.. (2016). Gene Transfection for Stem Cell Therapy. Current Stem Cell Reports. 2(1). 52–61. 21 indexed citations
16.
Tu, Chengyi, Loredana Santo, Yuko Mishima, et al.. (2016). Monitoring protein synthesis in single live cancer cells. Integrative Biology. 8(5). 645–653. 10 indexed citations
17.
Tu, Chengyi, et al.. (2015). Nanoscale Strategies: Treatment for Peripheral Vascular Disease and Critical Limb Ischemia. ACS Nano. 9(4). 3436–3452. 58 indexed citations
18.
Tu, Chengyi, Shengzhi Du, Barend Jacobus van Wyk, Karim Djouani, & Yskandar Hamam. (2011). High resolution Hough transform based on butterfly self-similarity. Electronics Letters. 47(25). 1360–1361. 2 indexed citations
19.
Sheu, Jang‐Ping, Jehn‐Ruey Jiang, & Chengyi Tu. (2008). Anonymous Path Routing in Wireless Sensor Networks. 2728–2734. 17 indexed citations
20.
Chang, Cheng‐Shang, D.-S. Lee, & Chengyi Tu. (2004). Recursive Construction of FIFO Optical Multiplexers With Switched Delay Lines. IEEE Transactions on Information Theory. 50(12). 3221–3233. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026